Permalink
Join GitHub today
GitHub is home to over 31 million developers working together to host and review code, manage projects, and build software together.
Sign up
translators/MEDLINEnbib.js
Find file
Copy path
Fetching contributors…
Cannot retrieve contributors at this time
{ | |
"translatorID": "9ec64cfd-bea7-472a-9557-493c0c26b0fb", | |
"label": "MEDLINE/nbib", | |
"creator": "Sebastian Karcher", | |
"target": "txt", | |
"minVersion": "4.0", | |
"maxVersion": "", | |
"priority": 100, | |
"inRepository": true, | |
"translatorType": 1, | |
"browserSupport": "gcsv", | |
"lastUpdated": "2015-10-16 18:47:13" | |
} | |
/* | |
***** BEGIN LICENSE BLOCK ***** | |
MEDLINE/nbib import translator | |
(Based on http://www.nlm.nih.gov/bsd/mms/medlineelements.html) | |
Copyright © 2014-15 Sebastian Karcher | |
This file is part of Zotero. | |
Zotero is free software: you can redistribute it and/or modify | |
it under the terms of the GNU Affero General Public License as published by | |
the Free Software Foundation, either version 3 of the License, or | |
(at your option) any later version. | |
Zotero is distributed in the hope that it will be useful, | |
but WITHOUT ANY WARRANTY; without even the implied warranty of | |
MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the | |
GNU Affero General Public License for more details. | |
You should have received a copy of the GNU Affero General Public License | |
along with Zotero. If not, see <http://www.gnu.org/licenses/>. | |
***** END LICENSE BLOCK ***** | |
*/ | |
function detectImport() { | |
var line; | |
var i = 0; | |
while ((line = Zotero.read()) !== false) { | |
line = line.replace(/^\s+/, ""); | |
if (line != "") { | |
//Actual MEDLINE format starts with PMID | |
if (line.substr(0, 6).match(/^PMID( {1, 2})?- /)) { | |
return true; | |
} else { | |
if (i++ > 3) { | |
return false; | |
} | |
} | |
} | |
} | |
} | |
var fieldMap = { | |
TI: "title", | |
VI: "volume", | |
IP: "issue", | |
PL: "place", | |
PB: "publisher", //not in the specs, but is used | |
BTI: "bookTitle", | |
JT: "publicationTitle", | |
TA: "journalAbbreviation", | |
PG: "pages", | |
CI: "rights", | |
ISBN: "ISBN", | |
ISSN: "ISSN", | |
LA: "language", | |
EN: "edition", | |
AB: "abstractNote" | |
}; | |
// Only the most basic types. Most official MEDLINE types make little sense as item types | |
var inputTypeMap = { | |
"Book": "book", | |
"Book Chapter": "bookSection", //can't find in specs, but is used. | |
"Journal Article": "journalArticle", | |
"Newspaper Article": "newspaperArticle", | |
"Video-Audio Media": "videoRecording", | |
"Technical Report": "report", | |
"Legal Case": "case", | |
"Legislation": "statute" | |
}; | |
var isEndNote = false; | |
function processTag(item, tag, value) { | |
value = Zotero.Utilities.trim(value); | |
if (fieldMap[tag]) { | |
item[fieldMap[tag]] = value; | |
} else if (tag == "PT") { | |
if (inputTypeMap[value]) { // first check inputTypeMap | |
item.itemType = inputTypeMap[value] | |
} | |
} else if (tag == "FAU" || tag == "FED") { | |
if (tag == "FAU") { | |
var type = "author"; | |
} else if (tag == "FED") { | |
var type = "editor"; | |
} | |
item.creators.push(Zotero.Utilities.cleanAuthor(value, type, value.indexOf(",") != -1)); | |
} else if (tag == "AU" || tag == "ED") { //save normal author tags as fallback | |
if (tag == "AU") { | |
var type = "author"; | |
} else if (tag == "ED") { | |
var type = "editor"; | |
} | |
value = value.replace(/\s([A-Z]+)$/, ", $1") | |
item.creatorsBackup.push(Zotero.Utilities.cleanAuthor(value, type, value.indexOf(",") != -1)); | |
} else if (tag == "PMID") { | |
item.extra = "PMID: " + value; | |
} else if (tag == "PMC") { | |
item.extra += " \nPMCID: " + value; | |
} else if (tag == "IS") { | |
var newline = ""; | |
if (ZU.cleanISSN(value)){ | |
if (!item.ISSN){ | |
item.ISSN =ZU.cleanISSN(value); | |
} | |
else { | |
item.ISSN += " " + ZU.cleanISSN(value); | |
} | |
} | |
else if (ZU.cleanISBN(value)){ | |
if (!item.ISBN){ | |
item.ISBN =ZU.cleanISBN(value); | |
} | |
else { | |
item.ISBN += " " + ZU.cleanISBN(value); | |
} | |
} | |
} else if (tag == "AID") { | |
if (value.indexOf("[doi]") != -1) item.DOI = value.replace(/\s*\[doi\]/, "") | |
} else if (tag == "DP") { | |
item.date = value; | |
} else if (tag == "MH" || tag == "OT") { | |
item.tags.push(value); | |
} | |
} | |
function doImport() { | |
var line = true; | |
var tag = data = false; | |
do { // first valid line is type | |
Zotero.debug("ignoring " + line); | |
line = Zotero.read(); | |
line = line.replace(/^\s+/, ""); | |
} while (line !== false && line.search(/^[A-Z0-9]+\s*-/) == -1); | |
var item = new Zotero.Item(); | |
item.creatorsBackup = []; | |
var tag = line.match(/^[A-Z0-9]+/)[0]; | |
var data = line.substr(line.indexOf("-") + 1); | |
while ((line = Zotero.read()) !== false) { // until EOF | |
line = line.replace(/^\s+/, ""); | |
if (!line) { | |
if (tag) { | |
processTag(item, tag, data); | |
// unset info | |
tag = data = false; | |
// new item | |
finalizeItem(item) | |
item = new Zotero.Item(); | |
item.creatorsBackup = []; | |
} | |
} else if (line.search(/^[A-Z0-9]+\s*-/) != -1) { | |
// if this line is a tag, take a look at the previous line to map | |
// its tag | |
if (tag) { | |
processTag(item, tag, data); | |
} | |
// then fetch the tag and data from this line | |
tag = line.match(/^[A-Z0-9]+/)[0]; | |
data = line.substr(line.indexOf("-") + 1); | |
} else { | |
// otherwise, assume this is data from the previous line continued | |
if (tag) { | |
data += " " + line; | |
} | |
} | |
} | |
if (tag) { // save any unprocessed tags | |
processTag(item, tag, data); | |
// and finalize with some post-processing | |
finalizeItem(item) | |
} | |
} | |
function finalizeItem(item) { | |
//if we didn't get full authors (included post 2002, sub in the basic authors) | |
if (item.creators.length == 0 && item.creatorsBackup.length > 0) { | |
item.creators = item.creatorsBackup; | |
} | |
delete item.creatorsBackup; | |
if (item.pages) { | |
//where page ranges are given in an abbreviated format, convert to full | |
//taken verbatim from NCBI Pubmed translator | |
var pageRangeRE = /(\d+)-(\d+)/g; | |
pageRangeRE.lastIndex = 0; | |
var range; | |
while (range = pageRangeRE.exec(item.pages)) { | |
var pageRangeStart = range[1]; | |
var pageRangeEnd = range[2]; | |
var diff = pageRangeStart.length - pageRangeEnd.length; | |
if (diff > 0) { | |
pageRangeEnd = pageRangeStart.substring(0,diff) + pageRangeEnd; | |
var newRange = pageRangeStart + "-" + pageRangeEnd; | |
var fullPageRange = item.pages.substring(0, range.index) //everything before current range | |
+ newRange //insert the new range | |
+ item.pages.substring(range.index + range[0].length); //everything after the old range | |
//adjust RE index | |
pageRangeRE.lastIndex += newRange.length - range[0].length; | |
} | |
} | |
if (fullPageRange){ | |
item.pages = fullPageRange; | |
} | |
} | |
//journal article is the fallback item type | |
if (!item.itemType) item.itemType = inputTypeMap["Journal Article"]; | |
//titles for books are mapped to bookTitle | |
if (item.itemType == "book") item.title = item.bookTitle; | |
item.complete(); | |
}/** BEGIN TEST CASES **/ | |
var testCases = [ | |
{ | |
"type": "import", | |
"input": "PMID- 8692918\nOWN - NLM\nSTAT- MEDLINE\nDA - 19960829\nDCOM- 19960829\nLR - 20131121\nIS - 0027-8424 (Print)\nIS - 0027-8424 (Linking)\nVI - 93\nIP - 14\nDP - 1996 Jul 9\nTI - The structure of bovine F1-ATPase complexed with the antibiotic inhibitor\n aurovertin B.\nPG - 6913-7\nAB - In the structure of bovine mitochondrial F1-ATPase that was previously determined\n with crystals grown in the presence of adenylyl-imidodiphosphate (AMP-PNP) and\n ADP, the three catalytic beta-subunits have different conformations and\n nucleotide occupancies. Adenylyl-imidodiphosphate is bound to one beta-subunit\n (betaTP), ADP is bound to the second (betaDP), and no nucleotide is bound to the \n third (betaE). Here we show that the uncompetitive inhibitor aurovertin B binds\n to bovine F1 at two equivalent sites in betaTP and betaE, in a cleft between the \n nucleotide binding and C-terminal domains. In betaDP, the aurovertin B pocket is \n incomplete and is inaccessible to the inhibitor. The aurovertin B bound to betaTP\n interacts with alpha-Glu399 in the adjacent alphaTP subunit, whereas the\n aurovertin B bound to betaE is too distant from alphaE to make an equivalent\n interaction. Both sites encompass betaArg-412, which was shown by mutational\n studies to be involved in binding aurovertin. Except for minor changes around the\n aurovertin pockets, the structure of bovine F1-ATPase is the same as determined\n previously. Aurovertin B appears to act by preventing closure of the catalytic\n interfaces, which is essential for a catalytic mechanism involving cyclic\n interconversion of catalytic sites.\nFAU - van Raaij, M J\nAU - van Raaij MJ\nAD - Medical Research Council Laboratory of Molecular Biology, Cambridge, United\n Kingdom.\nFAU - Abrahams, J P\nAU - Abrahams JP\nFAU - Leslie, A G\nAU - Leslie AG\nFAU - Walker, J E\nAU - Walker JE\nLA - eng\nPT - Journal Article\nPT - Research Support, Non-U.S. Gov't\nPL - UNITED STATES\nTA - Proc Natl Acad Sci U S A\nJT - Proceedings of the National Academy of Sciences of the United States of America\nJID - 7505876\nRN - 0 (Aurovertins)\nRN - 0 (Enzyme Inhibitors)\nRN - 0 (Macromolecular Substances)\nRN - 25612-73-1 (Adenylyl Imidodiphosphate)\nRN - 3KX376GY7L (Glutamic Acid)\nRN - 55350-03-3 (aurovertin B)\nRN - 94ZLA3W45F (Arginine)\nRN - EC 3.6.3.14 (Proton-Translocating ATPases)\nSB - IM\nMH - Adenylyl Imidodiphosphate/pharmacology\nMH - Animals\nMH - Arginine\nMH - Aurovertins/*chemistry/*metabolism\nMH - Binding Sites\nMH - Cattle\nMH - Crystallography, X-Ray\nMH - Enzyme Inhibitors/chemistry/metabolism\nMH - Glutamic Acid\nMH - Macromolecular Substances\nMH - Models, Molecular\nMH - Molecular Structure\nMH - Myocardium/enzymology\nMH - *Protein Structure, Secondary\nMH - Proton-Translocating ATPases/*chemistry/*metabolism\nPMC - PMC38908\nOID - NLM: PMC38908\nEDAT- 1996/07/09\nMHDA- 1996/07/09 00:01\nCRDT- 1996/07/09 00:00\nPST - ppublish\nSO - Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6913-7.\n\nPMID- 21249755\nSTAT- Publisher\nDA - 20110121\nDRDT- 20080809\nCTDT- 20080718\nPB - National Center for Biotechnology Information (US)\nDP - 2009\nTI - Peutz-Jeghers Syndrome\nBTI - Cancer Syndromes\nAB - PJS is a rare disease. (\"Peutz-Jeghers syndrome is no frequent nosological unit\".\n (1)) There are no high-quality estimates of the prevalence or incidence of PJS.\n Estimates have included 1 in 8,500 to 23,000 live births (2), 1 in 50,000 to 1 in\n 100,000 in Finland (3), and 1 in 200,000 (4). A report on the incidence of PJS is\n available at www.peutz-jeghers.com. At Mayo Clinic from 1945 to 1996 the\n incidence of PJS was 0.9 PJS patients per 100,000 patients. PJS has been reported\n in Western Europeans (5), African Americans (5), Nigerians (6), Japanese (7),\n Chinese (8, 9), Indians (10, 11), and other populations (12-15). PJS occurs\n equally in males and females (7).\nCI - Copyright (c) 2009-, Douglas L Riegert-Johnson\nFED - Riegert-Johnson, Douglas L\nED - Riegert-Johnson DL\nFED - Boardman, Lisa A\nED - Boardman LA\nFED - Hefferon, Timothy\nED - Hefferon T\nFED - Roberts, Maegan\nED - Roberts M\nFAU - Riegert-Johnson, Douglas\nAU - Riegert-Johnson D\nFAU - Gleeson, Ferga C.\nAU - Gleeson FC\nFAU - Westra, Wytske\nAU - Westra W\nFAU - Hefferon, Timothy\nAU - Hefferon T\nFAU - Wong Kee Song, Louis M.\nAU - Wong Kee Song LM\nFAU - Spurck, Lauren\nAU - Spurck L\nFAU - Boardman, Lisa A.\nAU - Boardman LA\nLA - eng\nPT - Book Chapter\nPL - Bethesda (MD)\nEDAT- 2011/01/21 06:00\nMHDA- 2011/01/21 06:00\nCDAT- 2011/01/21 06:00\nAID - NBK1826 [bookaccession]\n\n", | |
"items": [ | |
{ | |
"itemType": "journalArticle", | |
"title": "The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B.", | |
"creators": [ | |
{ | |
"firstName": "M. J.", | |
"lastName": "van Raaij", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "J. P.", | |
"lastName": "Abrahams", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "A. G.", | |
"lastName": "Leslie", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "J. E.", | |
"lastName": "Walker", | |
"creatorType": "author" | |
} | |
], | |
"date": "1996 Jul 9", | |
"ISSN": "0027-8424 0027-8424", | |
"abstractNote": "In the structure of bovine mitochondrial F1-ATPase that was previously determined with crystals grown in the presence of adenylyl-imidodiphosphate (AMP-PNP) and ADP, the three catalytic beta-subunits have different conformations and nucleotide occupancies. Adenylyl-imidodiphosphate is bound to one beta-subunit (betaTP), ADP is bound to the second (betaDP), and no nucleotide is bound to the third (betaE). Here we show that the uncompetitive inhibitor aurovertin B binds to bovine F1 at two equivalent sites in betaTP and betaE, in a cleft between the nucleotide binding and C-terminal domains. In betaDP, the aurovertin B pocket is incomplete and is inaccessible to the inhibitor. The aurovertin B bound to betaTP interacts with alpha-Glu399 in the adjacent alphaTP subunit, whereas the aurovertin B bound to betaE is too distant from alphaE to make an equivalent interaction. Both sites encompass betaArg-412, which was shown by mutational studies to be involved in binding aurovertin. Except for minor changes around the aurovertin pockets, the structure of bovine F1-ATPase is the same as determined previously. Aurovertin B appears to act by preventing closure of the catalytic interfaces, which is essential for a catalytic mechanism involving cyclic interconversion of catalytic sites.", | |
"extra": "PMID: 8692918 \nPMCID: PMC38908", | |
"issue": "14", | |
"journalAbbreviation": "Proc Natl Acad Sci U S A", | |
"language": "eng", | |
"pages": "6913-6917", | |
"publicationTitle": "Proceedings of the National Academy of Sciences of the United States of America", | |
"volume": "93", | |
"attachments": [], | |
"tags": [ | |
"*Protein Structure, Secondary", | |
"Adenylyl Imidodiphosphate/pharmacology", | |
"Animals", | |
"Arginine", | |
"Aurovertins/*chemistry/*metabolism", | |
"Binding Sites", | |
"Cattle", | |
"Crystallography, X-Ray", | |
"Enzyme Inhibitors/chemistry/metabolism", | |
"Glutamic Acid", | |
"Macromolecular Substances", | |
"Models, Molecular", | |
"Molecular Structure", | |
"Myocardium/enzymology", | |
"Proton-Translocating ATPases/*chemistry/*metabolism" | |
], | |
"notes": [], | |
"seeAlso": [] | |
}, | |
{ | |
"itemType": "bookSection", | |
"title": "Peutz-Jeghers Syndrome", | |
"creators": [ | |
{ | |
"firstName": "Douglas L.", | |
"lastName": "Riegert-Johnson", | |
"creatorType": "editor" | |
}, | |
{ | |
"firstName": "Lisa A.", | |
"lastName": "Boardman", | |
"creatorType": "editor" | |
}, | |
{ | |
"firstName": "Timothy", | |
"lastName": "Hefferon", | |
"creatorType": "editor" | |
}, | |
{ | |
"firstName": "Maegan", | |
"lastName": "Roberts", | |
"creatorType": "editor" | |
}, | |
{ | |
"firstName": "Douglas", | |
"lastName": "Riegert-Johnson", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Ferga C.", | |
"lastName": "Gleeson", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Wytske", | |
"lastName": "Westra", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Timothy", | |
"lastName": "Hefferon", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Louis M.", | |
"lastName": "Wong Kee Song", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Lauren", | |
"lastName": "Spurck", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "Lisa A.", | |
"lastName": "Boardman", | |
"creatorType": "author" | |
} | |
], | |
"date": "2009", | |
"abstractNote": "PJS is a rare disease. (\"Peutz-Jeghers syndrome is no frequent nosological unit\". (1)) There are no high-quality estimates of the prevalence or incidence of PJS. Estimates have included 1 in 8,500 to 23,000 live births (2), 1 in 50,000 to 1 in 100,000 in Finland (3), and 1 in 200,000 (4). A report on the incidence of PJS is available at www.peutz-jeghers.com. At Mayo Clinic from 1945 to 1996 the incidence of PJS was 0.9 PJS patients per 100,000 patients. PJS has been reported in Western Europeans (5), African Americans (5), Nigerians (6), Japanese (7), Chinese (8, 9), Indians (10, 11), and other populations (12-15). PJS occurs equally in males and females (7).", | |
"bookTitle": "Cancer Syndromes", | |
"extra": "PMID: 21249755", | |
"language": "eng", | |
"place": "Bethesda (MD)", | |
"publisher": "National Center for Biotechnology Information (US)", | |
"rights": "Copyright (c) 2009-, Douglas L Riegert-Johnson", | |
"attachments": [], | |
"tags": [], | |
"notes": [], | |
"seeAlso": [] | |
} | |
] | |
}, | |
{ | |
"type": "import", | |
"input": "\nPMID- 8402898\nOWN - NLM\nSTAT- MEDLINE\nDA - 19931118\nDCOM- 19931118\nLR - 20061115\nIS - 0092-8674 (Print)\nIS - 0092-8674 (Linking)\nVI - 75\nIP - 1\nDP - 1993 Oct 8\nTI - The GTPase dynamin binds to and is activated by a subset of SH3 domains.\nPG - 25-36\nAB - Src homology 3 (SH3) domains have been implicated in mediating protein-protein\n interactions in receptor signaling processes; however, the precise role of this\n domain remains unclear. In this report, affinity purification techniques were\n used to identify the GTPase dynamin as an SH3 domain-binding protein. Selective\n binding to a subset of 15 different recombinant SH3 domains occurs through\n proline-rich sequence motifs similar to those that mediate the interaction of the\n SH3 domains of Grb2 and Abl proteins to the guanine nucleotide exchange protein, \n Sos, and to the 3BP1 protein, respectively. Dynamin GTPase activity is stimulated\n by several of the bound SH3 domains, suggesting that the function of the SH3\n module is not restricted to protein-protein interactions but may also include the\n interactive regulation of GTP-binding proteins.\nFAU - Gout, I\nAU - Gout I\nAD - Ludwig Institute for Cancer Research, London, England.\nFAU - Dhand, R\nAU - Dhand R\nFAU - Hiles, I D\nAU - Hiles ID\nFAU - Fry, M J\nAU - Fry MJ\nFAU - Panayotou, G\nAU - Panayotou G\nFAU - Das, P\nAU - Das P\nFAU - Truong, O\nAU - Truong O\nFAU - Totty, N F\nAU - Totty NF\nFAU - Hsuan, J\nAU - Hsuan J\nFAU - Booker, G W\nAU - Booker GW\nAU - et al.\nLA - eng\nPT - Comparative Study\nPT - Journal Article\nPT - Research Support, Non-U.S. Gov't\nPL - UNITED STATES\nTA - Cell\nJT - Cell\nJID - 0413066\nRN - 0 (Recombinant Fusion Proteins)\nRN - 0 (Recombinant Proteins)\nRN - EC 2.5.1.18 (Glutathione Transferase)\nRN - EC 3.6.1.- (GTP Phosphohydrolases)\nRN - EC 3.6.5.5 (Dynamins)\nSB - IM\nMH - Amino Acid Sequence\nMH - Animals\nMH - Binding Sites\nMH - Brain/*enzymology\nMH - Drosophila/genetics\nMH - Dynamins\nMH - Enzyme Activation\nMH - GTP Phosphohydrolases/isolation & purification/*metabolism\nMH - Glutathione Transferase/metabolism\nMH - Humans\nMH - Kinetics\nMH - Mice\nMH - Molecular Sequence Data\nMH - Rats\nMH - Recombinant Fusion Proteins/metabolism\nMH - Recombinant Proteins/isolation & purification/metabolism\nMH - Sequence Homology, Amino Acid\nMH - Signal Transduction\nEDAT- 1993/10/08\nMHDA- 1993/10/08 00:01\nCRDT- 1993/10/08 00:00\nAID - 0092-8674(93)90676-H [pii]\nPST - ppublish\nSO - Cell. 1993 Oct 8;75(1):25-36.", | |
"items": [ | |
{ | |
"itemType": "journalArticle", | |
"title": "The GTPase dynamin binds to and is activated by a subset of SH3 domains.", | |
"creators": [ | |
{ | |
"firstName": "I.", | |
"lastName": "Gout", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "R.", | |
"lastName": "Dhand", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "I. D.", | |
"lastName": "Hiles", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "M. J.", | |
"lastName": "Fry", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "G.", | |
"lastName": "Panayotou", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "P.", | |
"lastName": "Das", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "O.", | |
"lastName": "Truong", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "N. F.", | |
"lastName": "Totty", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "J.", | |
"lastName": "Hsuan", | |
"creatorType": "author" | |
}, | |
{ | |
"firstName": "G. W.", | |
"lastName": "Booker", | |
"creatorType": "author" | |
} | |
], | |
"date": "1993 Oct 8", | |
"ISSN": "0092-8674 0092-8674", | |
"abstractNote": "Src homology 3 (SH3) domains have been implicated in mediating protein-protein interactions in receptor signaling processes; however, the precise role of this domain remains unclear. In this report, affinity purification techniques were used to identify the GTPase dynamin as an SH3 domain-binding protein. Selective binding to a subset of 15 different recombinant SH3 domains occurs through proline-rich sequence motifs similar to those that mediate the interaction of the SH3 domains of Grb2 and Abl proteins to the guanine nucleotide exchange protein, Sos, and to the 3BP1 protein, respectively. Dynamin GTPase activity is stimulated by several of the bound SH3 domains, suggesting that the function of the SH3 module is not restricted to protein-protein interactions but may also include the interactive regulation of GTP-binding proteins.", | |
"extra": "PMID: 8402898", | |
"issue": "1", | |
"journalAbbreviation": "Cell", | |
"language": "eng", | |
"pages": "25-36", | |
"publicationTitle": "Cell", | |
"volume": "75", | |
"attachments": [], | |
"tags": [ | |
"Amino Acid Sequence", | |
"Animals", | |
"Binding Sites", | |
"Brain/*enzymology", | |
"Drosophila/genetics", | |
"Dynamins", | |
"Enzyme Activation", | |
"GTP Phosphohydrolases/isolation & purification/*metabolism", | |
"Glutathione Transferase/metabolism", | |
"Humans", | |
"Kinetics", | |
"Mice", | |
"Molecular Sequence Data", | |
"Rats", | |
"Recombinant Fusion Proteins/metabolism", | |
"Recombinant Proteins/isolation & purification/metabolism", | |
"Sequence Homology, Amino Acid", | |
"Signal Transduction" | |
], | |
"notes": [], | |
"seeAlso": [] | |
} | |
] | |
}, | |
{ | |
"type": "import", | |
"input": "PMID- 25744111\nOWN - NLM\nSTAT- MEDLINE\nDA - 20150525\nDCOM- 20150819\nIS - 1476-5616 (Electronic)\nIS - 0033-3506 (Linking)\nVI - 129\nIP - 5\nDP - 2015 May\nTI - Effectiveness of public health practices against shaken baby syndrome/abusive\n head trauma in Japan.\nPG - 475-82\nLID - 10.1016/j.puhe.2015.01.018 [doi]\nLID - S0033-3506(15)00037-2 [pii]\nAB - OBJECTIVES: Previous studies have demonstrated the effectiveness of educational\n materials on infant crying to change caregivers' knowledge and behaviours related\n to shaken baby syndrome or abusive head trauma (SBS/AHT) using selected samples\n in randomized controlled trials. This study investigated the impact of public\n health practices to prevent SBS/AHT in Japan through the use of educational\n materials. STUDY DESIGN: Cross-sectional study. METHODS: The intervention was\n comprised of two parts: (1) the screening of an educational DVD at a prenatal\n class; and (2) the distribution of a public health pamphlet at a postnatal home\n visit. Expectant parents watched a DVD (The Period of PURPLE Crying) about the\n features of infant crying and recommended behaviours (walking away if frustrated \n in the event of unsoothable crying, sharing information on crying with other\n caregivers) at a preterm parenting class held at eight months' gestation. A\n postnatal home-visit service was implemented in which a maternity nurse\n distributed a pamphlet to explain information about infant crying. Before the\n four-month health check-up, a self-administered questionnaire was distributed to \n assess exposure to these public health practices and outcome variables (i.e.\n infant crying knowledge, walk-away and information-sharing behaviours), and\n responses were collected at the four-month health check-up (n = 1316). The\n impacts of these interventions on outcome variables were analysed by comparing\n those exposed to both interventions, either intervention and neither intervention\n after adjusting for covariates. RESULTS: Crying and shaking knowledge were\n significantly higher among women exposed to the public health practices, with a\n dose-response relationship (both P < 0.001). Further, walk-away behaviour during \n periods of unsoothable crying was higher among the intervention group. However,\n sharing information about infant crying with other caregivers was less likely\n among the intervention group. CONCLUSIONS: The impact of educational materials in\n public health practice on knowledge of crying and shaking, and walk-away\n behaviour in Japan had a dose-response relationship; however, an increase in\n sharing information with other caregivers was not observed.\nCI - Copyright (c) 2015 The Royal Society for Public Health. Published by Elsevier\n Ltd. All rights reserved.\nFAU - Fujiwara, T\nAU - Fujiwara T\nAD - Department of Social Medicine, National Research Institute for Child Health and\n Development, Okura, Setagaya-ku, Tokyo, Japan. Electronic address:\n fujiwara-tk@ncchd.go.jp.\nLA - eng\nPT - Evaluation Studies\nPT - Journal Article\nPT - Research Support, Non-U.S. Gov't\nDEP - 20150303\nPL - Netherlands\nTA - Public Health\nJT - Public health\nJID - 0376507\nSB - IM\nMH - Adolescent\nMH - Adult\nMH - Caregivers/*education/psychology/statistics & numerical data\nMH - Child Abuse/*prevention & control\nMH - Craniocerebral Trauma/*prevention & control\nMH - Cross-Sectional Studies\nMH - Crying/psychology\nMH - Female\nMH - Follow-Up Studies\nMH - *Health Knowledge, Attitudes, Practice\nMH - Humans\nMH - Infant\nMH - Infant, Newborn\nMH - Japan\nMH - Male\nMH - Pamphlets\nMH - Parents/*education/psychology\nMH - Program Evaluation\nMH - *Public Health Practice\nMH - Questionnaires\nMH - Shaken Baby Syndrome/*prevention & control\nMH - Videodisc Recording\nMH - Young Adult\nOTO - NOTNLM\nOT - Abusive head trauma\nOT - Crying\nOT - Intervention\nOT - Japan\nOT - Public health\nOT - Shaken baby syndrome\nEDAT- 2015/03/07 06:00\nMHDA- 2015/08/20 06:00\nCRDT- 2015/03/07 06:00\nPHST- 2014/05/29 [received]\nPHST- 2014/11/26 [revised]\nPHST- 2015/01/20 [accepted]\nPHST- 2015/03/03 [aheadofprint]\nAID - S0033-3506(15)00037-2 [pii]\nAID - 10.1016/j.puhe.2015.01.018 [doi]\nPST - ppublish\nSO - Public Health. 2015 May;129(5):475-82. doi: 10.1016/j.puhe.2015.01.018. Epub 2015\n Mar 3.", | |
"items": [ | |
{ | |
"itemType": "journalArticle", | |
"title": "Effectiveness of public health practices against shaken baby syndrome/abusive head trauma in Japan.", | |
"creators": [ | |
{ | |
"firstName": "T.", | |
"lastName": "Fujiwara", | |
"creatorType": "author" | |
} | |
], | |
"date": "2015 May", | |
"DOI": "10.1016/j.puhe.2015.01.018", | |
"ISSN": "1476-5616 0033-3506", | |
"abstractNote": "OBJECTIVES: Previous studies have demonstrated the effectiveness of educational materials on infant crying to change caregivers' knowledge and behaviours related to shaken baby syndrome or abusive head trauma (SBS/AHT) using selected samples in randomized controlled trials. This study investigated the impact of public health practices to prevent SBS/AHT in Japan through the use of educational materials. STUDY DESIGN: Cross-sectional study. METHODS: The intervention was comprised of two parts: (1) the screening of an educational DVD at a prenatal class; and (2) the distribution of a public health pamphlet at a postnatal home visit. Expectant parents watched a DVD (The Period of PURPLE Crying) about the features of infant crying and recommended behaviours (walking away if frustrated in the event of unsoothable crying, sharing information on crying with other caregivers) at a preterm parenting class held at eight months' gestation. A postnatal home-visit service was implemented in which a maternity nurse distributed a pamphlet to explain information about infant crying. Before the four-month health check-up, a self-administered questionnaire was distributed to assess exposure to these public health practices and outcome variables (i.e. infant crying knowledge, walk-away and information-sharing behaviours), and responses were collected at the four-month health check-up (n = 1316). The impacts of these interventions on outcome variables were analysed by comparing those exposed to both interventions, either intervention and neither intervention after adjusting for covariates. RESULTS: Crying and shaking knowledge were significantly higher among women exposed to the public health practices, with a dose-response relationship (both P < 0.001). Further, walk-away behaviour during periods of unsoothable crying was higher among the intervention group. However, sharing information about infant crying with other caregivers was less likely among the intervention group. CONCLUSIONS: The impact of educational materials in public health practice on knowledge of crying and shaking, and walk-away behaviour in Japan had a dose-response relationship; however, an increase in sharing information with other caregivers was not observed.", | |
"extra": "PMID: 25744111", | |
"issue": "5", | |
"journalAbbreviation": "Public Health", | |
"language": "eng", | |
"pages": "475-482", | |
"publicationTitle": "Public health", | |
"rights": "Copyright (c) 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.", | |
"volume": "129", | |
"attachments": [], | |
"tags": [ | |
"*Health Knowledge, Attitudes, Practice", | |
"*Public Health Practice", | |
"Abusive head trauma", | |
"Adolescent", | |
"Adult", | |
"Caregivers/*education/psychology/statistics & numerical data", | |
"Child Abuse/*prevention & control", | |
"Craniocerebral Trauma/*prevention & control", | |
"Cross-Sectional Studies", | |
"Crying", | |
"Crying/psychology", | |
"Female", | |
"Follow-Up Studies", | |
"Humans", | |
"Infant", | |
"Infant, Newborn", | |
"Intervention", | |
"Japan", | |
"Male", | |
"Pamphlets", | |
"Parents/*education/psychology", | |
"Program Evaluation", | |
"Public health", | |
"Questionnaires", | |
"Shaken Baby Syndrome/*prevention & control", | |
"Shaken baby syndrome", | |
"Videodisc Recording", | |
"Young Adult" | |
], | |
"notes": [], | |
"seeAlso": [] | |
} | |
] | |
} | |
] | |
/** END TEST CASES **/ |